1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders Moderna mRNA-1273, BNT162b2, Ad26.COV2.S - Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE) | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 258 | 2021-08-13 | 2026-06-10 |
Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Autoimmune Diseases (1) · COVID-19 (1) · Dermatomyositis (1) · Lupus Erythematosus, Systemic (1) · Multiple Sclerosis (1) · Pemphigus (1) · Scleroderma, Systemic (1)
Arthritis (1) · Autoimmune Diseases of the Nervous System (1) · Connective Tissue Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Infections (1) · Joint Diseases (1) · Lung Diseases (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Myositis (1) · Nervous System Diseases (1)
2019-nCoV Vaccine mRNA-1273 (1) · Ad26COVS1 (1) · BNT162 Vaccine (1) · BNT162b5 (1) · COVID-19 Vaccines (1) · Methotrexate (1) · Mycophenolic Acid (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)
Amit Bar-Or, MD, FRCP (1) · Dinesh Khanna, MBBS, MSc (1) · Judith A. James, MD, PhD (1) · Meggan C. Mackay, MD, MS (1) · Natasha Mckerran Ruth, MD (1) · Stacy Ardoin, MD (1) · Tracey Wright, MD (1) · Virginia Pascual, MD (1)